Lars Nyman

553 total citations
14 papers, 427 citations indexed

About

Lars Nyman is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Lars Nyman has authored 14 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Lars Nyman's work include Pneumonia and Respiratory Infections (4 papers), Gastroesophageal reflux and treatments (3 papers) and Pediatric health and respiratory diseases (3 papers). Lars Nyman is often cited by papers focused on Pneumonia and Respiratory Infections (4 papers), Gastroesophageal reflux and treatments (3 papers) and Pediatric health and respiratory diseases (3 papers). Lars Nyman collaborates with scholars based in Sweden, Germany and France. Lars Nyman's co-authors include Börje Åkerlund, Staffan Kjelleberg, Bernt Eric Uhlin, Staffan Normark, Ute Römling, Kerstin Röhss, Ronald Eccles, Clive H. Wilder‐Smith, Anders Berglund and Mats Ekelund and has published in prestigious journals such as Gastroenterology, PLoS ONE and Journal of Internal Medicine.

In The Last Decade

Lars Nyman

14 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Nyman Sweden 11 124 84 64 58 58 14 427
Vesta Valuckaite United States 11 359 2.9× 206 2.5× 33 0.5× 71 1.2× 116 2.0× 20 711
Erik Rahimi United States 7 158 1.3× 142 1.7× 79 1.2× 73 1.3× 57 1.0× 33 417
Silvia Cuenca Spain 5 208 1.7× 34 0.4× 48 0.8× 56 1.0× 92 1.6× 6 319
Michal Werbner Israel 9 175 1.4× 36 0.4× 30 0.5× 67 1.2× 93 1.6× 10 380
Budhadev Baral India 14 159 1.3× 96 1.1× 12 0.2× 42 0.7× 107 1.8× 28 459
Tokuwa Kanno United Kingdom 11 256 2.1× 65 0.8× 92 1.4× 71 1.2× 48 0.8× 21 477
Esi Lamousé‐Smith United States 9 191 1.5× 62 0.7× 60 0.9× 60 1.0× 124 2.1× 18 422
Susan Lapthorne Ireland 12 176 1.4× 97 1.2× 46 0.7× 45 0.8× 59 1.0× 19 414
K Y Pang United States 13 183 1.5× 196 2.3× 38 0.6× 51 0.9× 53 0.9× 14 625
Christina Kumpitsch Austria 7 216 1.7× 32 0.4× 12 0.2× 85 1.5× 62 1.1× 14 436

Countries citing papers authored by Lars Nyman

Since Specialization
Citations

This map shows the geographic impact of Lars Nyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Nyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Nyman more than expected).

Fields of papers citing papers by Lars Nyman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Nyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Nyman. The network helps show where Lars Nyman may publish in the future.

Co-authorship network of co-authors of Lars Nyman

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Nyman. A scholar is included among the top collaborators of Lars Nyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Nyman. Lars Nyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Berglund, Anders, Mats Ekelund, Mark A. Fletcher, & Lars Nyman. (2014). All-Cause Pneumonia Hospitalizations in Children <2 Years Old in Sweden, 1998 to 2012: Impact of Pneumococcal Conjugate Vaccine Introduction. PLoS ONE. 9(11). e112211–e112211. 37 indexed citations
3.
Römling, Ute, Staffan Kjelleberg, Staffan Normark, et al.. (2014). Microbial biofilm formation: a need to act. Journal of Internal Medicine. 276(2). 98–110. 125 indexed citations
4.
Wemer, Johan, et al.. (2006). Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects. Current Medical Research and Opinion. 22(9). 1813–1823. 12 indexed citations
5.
Wilder‐Smith, Clive H., et al.. (2005). Intravenous esomeprazole (40???mg and 20???mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies. European Journal of Gastroenterology & Hepatology. 17(2). 191–197. 18 indexed citations
6.
Praus, Michaela, et al.. (2004). Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin. The Journal of Clinical Pharmacology. 45(1). 57–67. 48 indexed citations
7.
Dörr, Helmuth G., Siegfried Zabransky, B. Otten, et al.. (2003). Are Needle-Free Injections a Useful Alternative for Growth Hormone Therapy in Children? Safety and Pharmacokinetics of Growth Hormone Delivered by a New Needle-Free Injection Device Compared to a Fine Gauge Needle. Journal of Pediatric Endocrinology and Metabolism. 16(3). 383–92. 33 indexed citations
8.
9.
10.
11.
Hassan‐Alin, Mohammed, Kerstin Röhss, Tommy Andersson, & Lars Nyman. (2000). Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. Gastroenterology. 118(4). A16–A16. 16 indexed citations
12.
Paulsen, Otto, et al.. (1992). Efficacy and Tolerance of Roxithromycin in Comparison with Erythromycin Stearate in Patients with Lower Respiratory Tract Infections. Scandinavian Journal of Infectious Diseases. 24(2). 219–225. 6 indexed citations
13.
Niklasson, Bo, et al.. (1987). Nephropathia epidemica: incidence of clinical cases and antibody prevalence in an endemic area of Sweden. Epidemiology and Infection. 99(2). 559–562. 26 indexed citations
14.
Niklasson, Bo, Lars Nyman, Annika Linde, M Grandien, & Joel M. Dalrymple. (1983). An Epidemiological Survey of Nephropathia Epidemica in Sweden. Scandinavian Journal of Infectious Diseases. 15(3). 239–245. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vesta Valuckaite Breakdown of academic impact, for papers by Erik Rahimi Breakdown of academic impact, for papers by Silvia Cuenca Breakdown of academic impact, for papers by Michal Werbner Breakdown of academic impact, for papers by Budhadev Baral Breakdown of academic impact, for papers by Tokuwa Kanno Breakdown of academic impact, for papers by Esi Lamousé‐Smith Breakdown of academic impact, for papers by Susan Lapthorne Breakdown of academic impact, for papers by K Y Pang Breakdown of academic impact, for papers by Christina Kumpitsch
Rankless by CCL
2026